Copyright
©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2917-2929
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2917
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2917
Figure 2 APEX2 over-expression in liver cancer was validated in The Gene Expression Omnibus series.
A: GSE14520 and B: GSE22058 containing adjacent non-tumor and tumor tissues were subjected to detect the APEX2 mRNA level; C: The 60 paired adjacent non-tumor and tumor tissues of GSE64041 were included to show the expression intensity in the heatmap. cP < 0.001 vs adjacent non-tumor tissues. HCC: Hepatocellular carcinoma.
- Citation: Zheng R, Zhu HL, Hu BR, Ruan XJ, Cai HJ. Identification of APEX2 as an oncogene in liver cancer. World J Clin Cases 2020; 8(14): 2917-2929
- URL: https://www.wjgnet.com/2307-8960/full/v8/i14/2917.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i14.2917